Business Standard
Relief for Natco in Novartis heart medicine case from Delhi High Court
In a breather for Indian drugmakers, the Delhi High Court has advised an assistant patent controller to hear Hyderabad-based drugmaker Natco Pharma’s opposition to Novartis’ patent for its latest blockbuster heart failure drug (a combination of sacubitril and valsartan). This court decision is significant because it potentially opens the door for Indian drug […]
Read More